HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa.

AuthorsElisa Molinelli, Claudia Sapigni, Oriana Simonetti, Giulia Radi, Daisy Gambini, Andrea Maurizi, Giulio Rizzetto, Giovanni Marco D'Agostino, Annamaria Offidani
JournalDermatologic therapy (Dermatol Ther) Vol. 35 Issue 8 Pg. e15645 (08 2022) ISSN: 1529-8019 [Electronic] United States
PMID35716015 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • dupilumab
Topics
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized (adverse effects)
  • Dermatitis, Atopic (diagnosis, drug therapy)
  • Double-Blind Method
  • Hidradenitis Suppurativa (diagnosis, drug therapy)
  • Humans
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: